Chairman, Department of Internal Medicine
Cardiology
Dr. David J. Moliterno, MD
|
|
Give Review
David Moliterno practices Cardiology. He went to medical school at Virginia Commonwealth University School of Medicine. He over the years received 4 awards: "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification", "Whos Who in Medicine and Healthcare" and "Fellow (FACC)". David Moliterno has written publications. He has 100 publications published with PubMed. The lastest paper is: 'Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from ...' David Moliterno is registered with Medicare and accepts Medicare payments.
Publications
- Use of thienopyridine prior to presentation with non-ST-segment elevation Acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from ...
- Ageless benefits of transradial access for percutaneous Coronary revascularization.
- Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Co...
- Potential hazards of adding nonsteroidal anti-inflammatory drugs to antithrombotic therapy after Myocardial infarction: time for more than a gut check.
- Usefulness and Safety of Vorapaxar in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (from the TRACER Tri...
- The impact of left anterior descending Coronary artery length on survival following myocardial infarction: To the apex and beyond.
- Antiplatelet and anticoagulation therapy for Acute coronary syndromes.
- Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation Acute coronary syndromes. The TRACER Pharmacodynamic Substudy.
- High-risk coronary anatomy versus high-risk physiology as outcome predictors in Acute coronary syndromes.
- Association of Aspirin Dose and Vorapaxar Safety and Efficacy in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (from the TRACER Trial).
- QRS duration predicts death and hospitalization among patients with Atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study.
- Vorapaxar in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Graft Surgery: Subgroup Analysis from the TRACER Trial.
- The evolving role of cardiac troponin in the evaluation of cardiac disorders.
- The Value of High-Sensitivity Troponin in Assessing the Extent of Benefit Provided by Ticagrelor versus Clopidogrel in Non-ST-Segment Elevation Acute Coronary Syndromes.
- Cessation of dual antiplatelet treatment and cardiac events after percutaneous Coronary intervention (PARIS): 2 year results from a prospective observational study.
- Stent Thrombosis through the generations.
- Tissue necrosis factor α and targeting its receptor in ischaemic heart Disease.
- Remote ischemic preconditioning in elective percutaneous Coronary intervention does not protect myocardium nor mobilize endothelial progenitor cells.
- Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in Acute coronary syndrome (TRA{middle dot}CER) trial.
- Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: An APEX AMI substudy.
- Increased mortality among patients taking digoxin-analysis from the AFFIRM study.
- Zotarolimus-eluting stents among patients with renal impairment undergoing percutaneous Coronary intervention.
- Early and late outcome associated with bleeding events in the setting of dual antiplatelet therapy following stent placement.
- CT Angiography for Emergency Decision Making in Acute Coronary Syndromes: Applying Future Vision Now.
- Safety and Efficacy of PAR-1 Antagonists in Patients with Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials.
- Platelet protease-activated receptor antagonism in cardiovascular medicine.
- New Anticoagulants in Ischemic Heart Disease.
- Meta-Analysis of Long-Term Outcomes for Drug-Eluting Stents Versus Bare-Metal Stents in Primary Percutaneous Coronary Interventions for ST-Segment Elevation Myocardial...
- Antithrombotic therapy in patients with atrial fibrillation undergoing Coronary stenting: a north american perspective: executive summary.
- The Use of Drug-Eluting Stents Versus Bypass Surgery for Left Main Coronary Artery Disease.
- ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensu...
- Upstream Use of Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes: A Systematic Overview of Randomized...
- Beyond Aspirin and Clopidogrel: Is There a Need for Additional Antiplatelet Therapy in ACS?
- Is there an Association Between External Cardioversions and Long Term Mortality and Morbidity - Insights from the AFFIRM Study.
- Patient, Heal Thyself: The Ongoing Evolution of Patient Self-directed Care and Hand-Held Technology.
- unfractionated versus low-molecular-weight heparin for primary angioplasty-More data suggesting to go low.
- Increased doses of clopidogrel or aspirin did not prevent cardiovascular events.
- Inside-out access: a new method of lead placement for patients with central venous occlusions.
- Long-term follow-up of drug-eluting stents placed in the setting of ST-segment elevation Myocardial infarction.
- Editorial: protein C and S deficiency as a risk factor for stent Thrombosis--when a rare disorder can predispose to rare events.
- Stent Thrombosis.
- Hormone replacement therapy among postmenopausal women presenting with Acute myocardial infarction: insights from the GUSTO-III trial.
- Rotational atherectomy for resistant Chronic total occlusions: another spin for tough old problems.
- The use of single versus dual antiplatelet therapy beyond 1 year following drug-eluting stent implantation.
- American College of Cardiology Annual Scientific Session 2010: update in interventional cardiology.
- The evolution of a Department of Internal Medicine under an integrated clinical enterprise model: the University of Kentucky experience.
- Second-generation drug-eluting stents and the continuous need for rapidly available real-world data.
- Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin...
- Prasugrel versus clopidogrel in primary PCI: considerations of the TRITON-TIMI 38 substudy.
- Left main and multivessel Coronary artery stenting for patients deemed inoperable-A real need for a tandem approach.
- Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparin.
- Combining antiplatelet and anticoagulant therapies.
- Antiplatelet polypharmacy in primary percutaneous Coronary intervention: trying to understand when more is better.
- G-protein-coupled receptors as signaling targets for antiplatelet therapy.
- Bare-metal versus drug-eluting stent placement among patients presenting with anemia.
- Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation Acute coronary syndromes undergoing diagnostic angiogr...
- Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused ...
- Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous Coronary intervention: a randomised, double-blind, placebo-controlled phase II study.
- Trifurcation left main Coronary artery percutaneous revascularization--pushing catheters and envelopes.
- Advances in antiplatelet therapy for ACS and PCI.
- Racial differences in outcome following percutaneous Coronary intervention.
- Late percutaneous recanalization of totally occluded infarct-related arteries--more than about time.
- Role of cardiac computed tomography and magnetic resonance imaging in the evaluation of Acute chest pain in the emergency department.
- Meta-analysis comparing reported frequency of atrial fibrillation after Acute coronary syndromes in Asians versus whites.
- Late target lesion revascularization following drug-eluting stents - looking back and forward to success.
- The safety and efficacy of glycoprotein IIb/IIIa inhibitors for primary angioplasty: more options to choose and more time to decide.
- Effectiveness of drug-eluting stents in real-world patients.
- Optimal platelet inhibition in patients undergoing PCI: data from the Multicenter Registry of High-Risk Percutaneous Coronary Intervention and Adequate Platelet Inhibi...
- Unraveling questions surrounding clopidogrel resistance and stent Thrombosis: one less snag.
- President's page: drug-eluting stents in contemporary practice--a call for a real-world, open-entry, device-tracking registry.
- Restenosis following thin-strut bare-metal stents versus thick-strut drug-eluting stents.
- The challenge of quantifying exceedingly rare occurrences: we can only see what we see.
- In unstable Angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting?
- Randomized trial versus registry data--comparing apples and ORCHIDs.
- The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous Coronary intervention trials.
- Imminent extinction of brachy(saurus)therapy for the treatment of in-stent restenosis.
- Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous Coronary revascularization.
- Heparin-induced thrombocytopenia and cardiovascular Diseases.
- The relationship of obesity to ischemic outcomes following Coronary stent placement in contemporary practice.
- Brachytherapy for in-stent restenosis: a distant second choice to drug-eluting stent placement.
- A comparison of the clinical impact of bleeding measured by two different classifications among patients with Acute coronary syndromes.
- Clopidogrel for percutaneous Coronary revascularization: time for more pretreatment, retreatment, or both?
- Outcomes in African Americans and whites after percutaneous Coronary intervention.
- Left main dissection and Thrombosis in a young athlete.
- Healing Achilles--sirolimus versus paclitaxel.
- Resistance to antiplatelet resistance is it justified?
- Association of height with outcomes in patients with Acute myocardial infarction receiving reperfusion therapy.
- The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy O...
- Are we appropriately triaging patients with unstable Angina?
- Relationship of blood transfusion and clinical outcomes in patients with Acute coronary syndromes.
- Real-world bare metal stenting: identification of patients at low or very low risk of 9-month Coronary revascularization.
- Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous Coronary interv...
- Did we enjoy the debate but forget the patient?
- Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous Coronary intervention.
- Fractionating heparins and their clinical trial data--something for everyone.
- Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing Coronary stenting.
- Premature Myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis.
- The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among Acute coronary syndrome patients.
- Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration.
Schools
Virginia Commonwealth University School Of Medicine
Vanderbilt University
University Tex Sw Med School
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- Aortic Embolism and Thrombosis
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Whos Who in Medicine and Healthcare
- Fellow (FACC)
Education
-
Cleveland Clinic Foundation -
Vanderbilt University -
Virginia Commonwealth University School of Medicine
Hospital
-
University of Kentucky Albert B. Chandler Hospital
Drug Facts
| NPI NUMBER | 1144234154 | |
| NPPES Provider LastName | MOLITERNO | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 405360001 | |
| NPPES Provider State | KY | |
| Specialty Description | Cardiology | |
| Total Claim Count | 155.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1144234154 |
| Last Name Of The Provider | MOLITERNO |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. Charles L. Campbell, MD |
|
|
Dr. David B. Cassidy, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles R. Salters Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas F. Whayne Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Naresh Anjur-Kapali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David C. Booth, MD |
|
|
Dr. David L. Keedy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James K. Crager, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leo G. Horan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Avichai Eres, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew E. Wiisanen, MD |
|
|
Dr. Diego A. Franco, MD |
|
|
Dr. Jeffrey T. Brumfield, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig A. Chasen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin T. Scully, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jamie J. Jacobs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samy C. Elayi, MD
This Doctor is OpenDoctor Recommended.
|